The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Inclusion Criteria

• •Adults aged 55 to 90
• •Patients who meet "Probable Alzheimer's disease" and "Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)" criteria for dementia
• •Patients with CDR (clinical dementia rating) from 0.5 to 1 and MMSE-II over 18
• •Upon hearing and fully understanding the detailed explanation of this clinical trial, a person who has voluntarily decided to participate and agreed in writing to comply with the precautions
• •A person with a severe history of cancer/tuberculosis
• •A person who has or is taking psychiatric or peripheral/central nervous system drugs
• •A person who has contact dermatitis or sensitive skin abnormalities
• •Patients with a high fever of 40 degrees or higher based on eardrum body temperature
• •A person whose bleeding is identified within the last 3 months due to a common procedure/surgery that may affect vital signs
• •A person who is unable to perform MRI tests
• •Pregnant women
• •Patient with calcification in the brain identified by CT
• •Patient with allergic to contrast agents such as Definity or Gadovist
• •Other cases where the investigator judged that it is difficult to participate in the study;